Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Antel

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Brain : a Journal of Neurology|June 1, 1996
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopyP M Matthews, E Pioro, S Narayanan, et al.
Diabetes, Obesity & Metabolism|January 25, 2012
Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weightK Rohrbach, M A Thomas, S Glick, et al.
Neurology|October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisM Mehling, V Brinkmann, J Antel, et al.
Nature Medicine|October 4, 2000
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligandB Bielekova, B Goodwin, N Richert, et al.
Annals of Neurology|September 1, 1996
Clinical outcomes assessment in multiple sclerosisR Rudick, J Antel, C Confavreux, et al.
Annals of Neurology|October 23, 1997
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task ForceR Rudick, J Antel, C Confavreux, et al.
Molecular Psychiatry|July 27, 2016
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass indexA Hinney, M Kesselmeier, S Jall, et al.
Molecular Psychiatry|May 18, 2016
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass indexA Hinney, M Kesselmeier, S Jall, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Brain : a Journal of Neurology|June 1, 1996
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopyP M Matthews, E Pioro, S Narayanan, et al.
Diabetes, Obesity & Metabolism|January 25, 2012
Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weightK Rohrbach, M A Thomas, S Glick, et al.
Neurology|October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisM Mehling, V Brinkmann, J Antel, et al.
Nature Medicine|October 4, 2000
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligandB Bielekova, B Goodwin, N Richert, et al.
Annals of Neurology|September 1, 1996
Clinical outcomes assessment in multiple sclerosisR Rudick, J Antel, C Confavreux, et al.
Annals of Neurology|October 23, 1997
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task ForceR Rudick, J Antel, C Confavreux, et al.
Molecular Psychiatry|July 27, 2016
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass indexA Hinney, M Kesselmeier, S Jall, et al.
Molecular Psychiatry|May 18, 2016
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass indexA Hinney, M Kesselmeier, S Jall, et al.
Pageof 7